Acquisition Announced

Otsuka acquisition of Transcend Therapeutics

US$700m consideration

Announced Mar 2026

Advisers

Target
Transcend Therapeutics
Acquirer
Otsuka
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Pharma, Behavioral Health

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.